A PEER-REVIEWED JOURNAL OF RESEARCH AND CLINICAL MEDICINEISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Shwachman – Diamond Syndrome: Modern Genetic Aspects of a Ribosomapathy

DOI:10.31550/1727-2378-2020-19-10-33-36
For citation: Ipatova M.G. Shwachman — Diamond Syndrome: Modern Genetic Aspects of a Ribosomapathy. Doctor.Ru. 2020; 19(10): 33–36. (in Russian). DOI: 10.31550/1727-2378-2020-19-10-33-36
30 november 2020

Objective of the Review: To analyse new DNAJC21, EFL1, SRP54 mutations causing ribosome biogenesis defects and presenting with clinical symptoms similar to the symptoms of Shwachman – Diamond syndrome (SDS).

Key Points. SDS is a ribosomapathy and is characterised by pancreatic exocrine insufficiency, defective hematopoiesis, musculoskeletal anomalies, and a high risk of myelodysplastic syndrome and acute myeloid leukemia. About 90% of SDS patients have biallelic SBDS mutations. However, 10–20% of patients with a set of symptoms typical of SDS did not have any pathovars in SBDS gene; therefore, we searched for other candidate genes. In addition to SDS, genetic disorders associated with defected maturation, deficient structure or function of ribosomes and ribonucleoprotein complexes include Diamond – Blackfan anemia, cartilage and hair hypoplasy (McKusick type metaphyseal chondrodysplasia), congenital diskeratosis, 5q-syndrome, and others. These syndromes are similar to SDS. All these conditions are associated with medullary deficiency at least in one hematopoiesis chain. All five conditions are associated with a high risk of cancer.

Conclusion. SDS is a genetically determined condition belonging to ribosomapathies. Ribosomapathies are caused by mutations in genes that participate in the synthesis of ribosomal proteins and factors, functioning at various stages of their assembly, and give origin to a number of clinical phenotypes, including haematological malignancies and cancer. In clinical practice, SDS is diagnosed on the basis of typical clinical symptoms and if pathogenic SBDS mutations are present. The issue whether SDS is a genetic heterogenetic ribosomapathy or a mutation of other genes causing defective ribosome synthesis and SDS-like symptoms, is disputable and requires further research. 

Conflict of interest: The authors declares that she does not have any conflict of interests.

M.G. Ipatova — N.I. Pirogov Russian National Research Medical University (a Federal Government Autonomous Educational Institution of Higher Education), Russian Federation Ministry of Health; 1 Ostrovityanov St., Moscow, Russian Federation 117997. N.F. Filatov Municipal Clinical Children Hospital of Moscow Department of Health; 15 Sadovaya-Kudrinskaya Str., Moscow, Russian Federation 123001. eLIBRARY.RU SPIN:1837-5380. http://orcid.org/0000-0003-0295-4820. E-mail: mariachka1@mail.ru

Доктор.ру

Fig. Ribosomal cycle [23]

r6_1.jpg

Received: 25.09.2020

Accepted: 16.10.2020


30 November 18:26
REFERENCES
  1. Shwachman H., Diamond L.K., Oski F.A. et al. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J. Pediatr. 1964; 65: 645–63. DOI: 10.1016/s0022-3476(64)80150-5
  2. Boocock G.R., Morrison J.A., Popovic M. et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 2003; 33(1): 97–101. DOI: 10.1016/j.hoc.2009.01.007
  3. Smith O.P., Hann I.M., Chessells J.M. et al. Haematological abnormalities in Shwachman-Diamond syndrome. Br. J. Haematol. 1996; 94(2): 279–84. DOI: 10.1046/j.1365-2141.1996.d01-1788.x
  4. Burroughs L., Woolfrey A., Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol. Oncol. Clin. North Am. 2009; 23(2): 233–48. DOI: 10.1016/j.hoc.2009.01.007
  5. Ipatova M.G., Kutsev S.I., Shumilov P.V. et al. Summary of clinical recommendations for the management of patients with Schwachman — Diamond syndrome. Pediatria. Journal named after G.N. Speransky. 2016; 95(6): 181–6. (in Russian)
  6. Dror Y., Durie P., Ginzberg H. et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. Exp. Hematol. 2002, 30(7): 659–69. DOI: 10.1016/s0301-472x(02)00815-9
  7. Babushok D.V., Bessler M., Olson T.S. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk. Lymphoma. 2016; 57(3): 520–36. DOI: 10.3109/10428194.2015.1115041
  8. Goobie S., Popovic M., Morrison J. et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am. J. Hum. Genet. 2001; 68(4): 1048–54. DOI: 10.1086/319505
  9. Minelli A., Nicolis E., Cannioto Z. et al. Incidence of Shwachman-Diamond syndrome in Italy. Pediatr. Blood Cancer. 2012; 59(7): 1334–5. DOI: 10.1002/pbc.24260
  10. Alter B.P., Giri N., Savage S.A. et al. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2018; 103(1): 30–9. DOI: 10.3324/haematol.2017.178111
  11. Hashmi S.K., Allen C., Klaassen R. et al. Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. Clin. Genet. 2011; 79(5): 448–58. DOI: 10.1111/j.1399-0004.2010.01468.x
  12. Mukhina A.A., Kuzmenko N.B., Rodina Y.A. et al. Primary immunodeficiencies in Russia: data from the National Registry. Front. Immunol. 2020; 11: 1491. DOI: 10.3389/fimmu.2020.01491
  13. Woloszynek J.R., Rothbaum R.J., Rawls A.S. et al. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood. 2004; 104(12): 3588–90. DOI: 10.1182/blood-2004-04-1516
  14. Nicolis E., Bonizzato A., Assael B.M. et al. Identification of novel mutations in patients with Shwachman-Diamond syndrome. Hum. Mutat. 2005; 25(4): 410. DOI: 10.1002/humu.9324
  15. Donadieu J., Fenneteau O., Beaupain B. et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012; 97(9): 1312–9. DOI: 10.3324/haematol.2011.057489
  16. Zhang S., Shi M., Hui C.C. et al. Loss of the mouse ortholog of the Shwachman-Diamond syndrome gene (Sbds) results in early embryonic lethality. Mol. Cell Biol. 2006; 26(17): 6656–63. DOI: 10.1128/MCB.00091-06
  17. Nakashima E., Mabuchi A., Makita Y. et al. Novel SBDS mutations caused by gene conversion in Japanese patients with Shwachman-Diamond syndrome. Hum. Genet. 2004; 114(4): 345–8. DOI: 10.1007/s00439-004-1081-2
  18. Steele L., Rommens J.M., Stockley T. et al. De novo mutations causing Shwachman-Diamond syndrome and a founder mutation in SBDS in the French Canadian population. J. Investig. Genomics. 2014; 1(2): 38–41. DOI: 10.15406/jig.2014.01.00008
  19. Dror Y., Donadieu J., Koglmeier J. et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann. NY Acad. Sci. 2011; 1242(1): 40–55. DOI: 10.1111/j.1749-6632.2011.06349.x
  20. Tummala H., Walne A.J., Williams M. et al. Affiliations expand. DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to corruption in 60S ribosome subunit maturation. Am. J. Hum. Genet. 2016; 99(1): 115–24. DOI: 10.1016/j.ajhg.2016.05.002
  21. Dhanraj S., Matveev A., Li H. et al. Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome. Blood. 2017; 129(11): 1557–62. DOI: 10.1182/blood-2016-08-735431
  22. Stepensky P., Chacón-Flores M., Kim K.H. et al. Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond like syndrome. J. Med. Gen. 2017; 54(8): 558–66. DOI: 10.1136/jmedgenet-2016-104366
  23. Carapito R., Konantz M., Paillard C. et al. Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. J. Clin. Invest. 2017; 127(11): 4090–103. DOI: 10.1172/JCI92876
  24. Bellanne-Chantelot C., Schmaltz-Panneau B., Marty C. et al. Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome. Blood. 2018; 132(12): 1318–31. DOI: 10.1182/blood-2017-12-820308
  25. Tafforeau L., Zorbas C., Langhendries J.L. et al. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol. Cell. 2013; 51(4): 539–51. DOI: 10.1016/j.molcel.2013.08.011
  26. de la Cruz J., Karbstein K., Woolford J.L. Jr. Functions of ribosomal proteins in assembly of eukaryotic ribosomes in vivo. Annu Rev. Biochem. 2015; 84: 93–129. DOI: 10.1146/annurev-biochem-060614-033917
  27. Klinge S., Voigts-Hoffmann F., Leibundgut M. et al. Atomic structures of the eukaryotic ribosome. Trends Biochem. Sci. 2012; 37(5): 189–98. DOI: 10.1016/j.tibs.2012.02.007
  28. Austin K.M., Gupta M.L. Jr, Coats S.A. et al. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J. Clin. Invest. 2008; 118(4): 1511–18. DOI: 10.1172/JCI33764
  29. Finch A.J., Hilcenko C., Basse N. et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011; 25(9): 917–29. DOI: 10.1101/gad.623011
  30. Gartmann M., Blau M., Armache J.P. et al. Mechanism of eIF6-mediated inhibition of ribosomal subunit joining. J. Biol. Chem. 2010; 285(20): 14848–51. DOI: 10.1074/jbc.C109.096057
  31. Austin K.M., Leary R.J., Shimamura A. The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood. 2005; 106(4): 1253–8. DOI: 10.1182/blood-2005-02-0807
  32. Menne T.F., Goyenechea B., Sánchez-Puig N. et al. The Shwachman-Bodian- Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat. Genet. 2007; 39(4): 486–95. DOI: 10.1038/ng1994
  33. Wong C.C., Traynor D., Basse N. et al. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood. 2011; 118(16): 4305–12. DOI: 10.1182/blood-2011-06-353938
  34. Keenan R.J., Freymann D.M., Stroud R.M. et al. The signal recognition particle. Annu Rev. Biochem. 2001; 70: 755–75. DOI: 10.1146/annurev.biochem.70.1.755
  35. Akopian D., Shen K., Zhang X. et al. Signal recognition particle: an essential protein-targeting machine. Annu Rev. Biochem. 2013; 82: 693–721. DOI: 10.1146/annurev-biochem-072711-164732
  36. Drygin D., O'Brien S.E., Hannan R.D. et al. Targeting the nucleolus for cancer-specific activation of p53. Drug Discov. Today. 2014; 19(3): 259–65. DOI: 10.1016/j.drudis.2013.08.012
  37. Quin J.E., Devlin J.R., Cameron D. et al. Targeting the nucleolus for cancer intervention. Biochim. Biophys. Acta. 2014; 1842(6): 802–16. DOI: 10.1016/j.bbadis.2013.12.009
  38. Ganapathi K.A., Austin K.M., Lee C.-S. et al. The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood. 2007; 110(5): 1458–65. DOI: 10.1182/blood-2007-02-075184
  39. Draptchinskaia N., Gustavsson P., Andersson B. M. et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 1999; 21(2): 169–75. DOI: 10.1038/5951
  40. Ebert B.L. Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer. Leukemia. 2009; 23(7): 1252–6. DOI: 10.1038/leu.2009.53
  41. Heiss N.S., Knight S.W., Vulliamy T.J. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 1998; 19(1): 32–8. DOI: 10.1038/ng0598-32
  42. Ridanpää M., van Eenennaam H., Pelin K. et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell. 2001; 104: 195–203. DOI: 10.1016/s0092-8674(01)00205-7
  43. Vulliamy T.J., Marrone A., Knight S.W. et al. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006; 107(7): 2680–5. DOI: 10.1182/blood-2005-07-2622
  44. Warren A.J. Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome. Adv. Biol. Regul. 2018; 67: 109–27. DOI: 10.1016/j.jbior.2017.09.002
  45. Gazda H.T., Zhong R., Long L. et al. RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br. J. Haematol. 2004; 127(1): 105–13. DOI: 10.1111/j.1365-2141.2004.05152.x
  46. Mason P.J., Wilson D.B., Bessler M. Dyskeratosis congenital — a disease of dysfunctional telomere maintenance. Curr. Mol. Med. 2005; 5(2): 159–70. DOI: 10.2174/1566524053586581
  47. Vlachos A., Klein G.W., Lipton J.M. The Diamond-Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia. J. Pediatr. Hematol. Oncol. 2001; 23(6): 377–82. DOI: 10.1097/00043426-200108000-00015

Похожие статьи

News

1 October 10:52
A New Issue of Doctor.Ru Internal Medicine, Vol. 21, No. 6 (2022), Published

Find original articles and reviews covering various aspects of сardiology, gastroenterology, internal medicine and the interview with Professor Alexey Nikolaevich Kalyagin

7 July 17:16
A New Issue of Doctor.Ru Neurology Psychiatry, Vol. 21, No. 4 (2022), Published

Find original articles and reviews covering various aspects of neurology, psychiatry and the interview with Professor Alexander Vitalievich Amelin

12 May 11:25
A New Issue of Doctor.Ru Pediatrics, Vol. 21 No. 3 (2022), Published

See the original papers, reviews and clinical cases in headings Pulmonology, Rheumatology, Endocrinology, Neurology, Cross-disciplinary approach and Interview with with an Honoured Scientist of the Sakha (Yakutia) Republic Professor Maria Vasilievna Khandy

4 May 10:02
A New Issue of Doctor.Ru Internal Medicine, Vol. 21, No. 2 (2022), Published

Find original articles and reviews covering various aspects of gastroenterology, internal medicine, rheumatology, endocrinology, special section of postgraduate training and the interview with Professor Dmitry Alexeevich Sychev

18 March 00:00
A New Issue of Doctor.Ru Gynecology, Vol. 21 No. 1 (2022), Published

Find original articles and reviews covering various aspects of obstetrics, perinatology and gynecology, and the interview with Feldberg Dov, MD

All news